# South Korea Kidney Stones Market > South Korea Kidney Stones Market Research Report By Type (Calcium Oxalate Stones, Uric Acid, Struvite Kidney Stones, Cystine Stones, Calcium Phosphate Stones), By Treatment Type (Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, Percutaneous Nephrolithotomy) andBy Diagnosis (Ultrasound, Intravenous Pyelography, CT scan, X-Ray, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 5.23% - **2024:** $ 54 Million - **2025:** $ 56.82 Million - **2035:** $ 94.6 Million - **Key Players:** Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE) **Report ID:** MRFR/MED/51099-HCR · **Pages:** 200 · **Author:** Nidhi Mandole & Garvit Vyas · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-kidney-stones-market-52860 --- ## Market Summary ## South Korea Kidney Stones Market Overview As per MRFR analysis, the South Korea Kidney Stones Market Size was estimated at 52 (USD Million) in 2023. The South Korea Kidney Stones Market Industry is expected to grow from 54 (USD Million) in 2024 to 160 (USD Million) by 2035.The South Korea Kidney Stones Market CAGR (growth rate) is expected to be around 10.378% during the forecast period (2025 - 2035). ### Key South Korea Kidney Stones Market Trends Highlighted The South Korea Kidney Stones Market is undergoing notable shifts stemming from the increased awareness of kidney health among the populace. The rising prevalence of kidney stones in South Korea due to dietary and lifestyle changes has created a demand for effective treatments and preventive measures. This demand is also backed by government programs that seek to raise health awareness and encourage healthier eating habits to reduce the risk of stone development. The increasing rates of obesity and metabolic syndrome in this region, which are known to be associated with kidney stones, also serve as important market contributors. With a greater emphasis on preventative care by healthcare professionals, interest in diet therapy programs and stone analysis services is on the rise. Technological innovations in the field of diagnostic imaging and other laparoscopic surgery procedures are also improving patient treatment options, which is essential for those seeking rapid recovery and shorter hospital stays. There is room within the South Korean market for the creation of kidney health specific products such as supplements, beverages, and hydration solutions intended for stone prevention. These product offerings could be strengthened through partnerships with local healthcare providers. Trends show growth in the utilization of mobile health applications that educate patients on self-management and prevention of kidney stones. Stakeholders in the South Korea Kidney Stones Market can improve overall patient outcomes and quality of care by addressing these new opportunities and market needs. ## South Korea Kidney Stones Market Drivers ### Rising Incidence of Kidney Stones The South Korea Kidney Stones Market Industry is experiencing significant growth due to the increasing incidence of kidney stones among the population. According to a study conducted by the Korean Urological Association, the prevalence of kidney stones in South Korea has surged over the past decade, with a reported 70% increase in cases from 2010 to 2020. This alarming trend indicates that nearly 1 in 10 South Koreans will develop kidney stones in their lifetime, highlighting the urgency for effective treatment solutions. Established organizations like the Korean Society of Nephrology have been actively involved in raising awareness and providing education about kidney stones, contributing to early diagnosis and treatment, which in turn fuels the growth of the kidney stones market in the region. As healthcare providers continue to address this growing health issue, investment in better medical technologies and treatments is expected to drive market expansion significantly. ### Technological Advancements in Treatment The South Korea [Kidney Stones Market](../../../reports/kidney-stones-market-1745) Industry is poised for substantial growth due to rapid advancements in medical technology. Innovations in laser lithotripsy and minimally invasive surgical techniques are facilitating better patient outcomes. According to the Ministry of Health and Welfare in South Korea, the number of procedures performed using advanced technologies has increased by over 50% in the last five years. This shift has not only improved recovery times but has also led to an increase in the number of patients seeking treatment for kidney stones. Major hospitals in South Korea, such as Seoul National University Hospital, are at the forefront of implementing these advanced procedures, thereby enhancing the overall market landscape. ### Growing Awareness and Preventive Healthcare In the South Korea Kidney Stones Market Industry, the emphasis on preventive healthcare is driving market growth. Recent initiatives by the South Korean government to promote health awareness are pivotal in educating the public on kidney stone prevention through dietary changes and lifestyle modifications. According to recent reports from the Korean Nutrition Society, there has been a 30% rise in public workshops and seminars focused on preventive measures against kidney stones. The increase in health literacy among the population, supported by government campaigns, is resulting in earlier intervention, which further stimulates the demand for kidney stone treatments and related services. ## South Korea Kidney Stones Market Segment Insights ### Kidney Stones Market Type Insights The South Korea Kidney Stones Market segmentation by Type reveals significant insights into the prevalence and treatment options available for various kinds of kidney stones affecting the population. Among these types, Calcium Oxalate Stones due to their high formation rates in the south of Korea account for a majority holding in the market, often attributed to dietary habits heavy in oxalate-rich foods. Uric Acid stones, while less common, are seeing a rise in prevalence, particularly among individuals with metabolic syndromes, presenting opportunities for targeted treatment and prevention strategies. Struvite Kidney Stones, which often arise as a result of urinary tract infections, reflect a different set of challenges in healthcare management, as they require both addressing the stones and the underlying infections. Cystine Stones, although less frequently encountered, predominantly affect those with the rare genetic disorder cystinuria and bring forth the need for specialized medical interventions and robust patient education regarding hydration and dietary modifications. Lastly, Calcium Phosphate Stones are often associated with certain metabolic disorders and are becoming increasingly significant as awareness grows regarding associated health conditions, leading to proactive healthcare measures. As the South Korea Kidney Stones Market continues to evolve, understanding these segments not only aids in addressing patient care but also emphasizes the need for tailored prevention and educational programs to potentially reduce incidences across the varying types of kidney stones. ### Kidney Stones Market Treatment Type Insights The South Korea Kidney Stones Market is witnessing significant advancements in treatment options classified under the Treatment Type segment. This market encompasses various methods including Medications, Extracorporeal Shock Wave Lithotripsy, Ureteroscopy, and Percutaneous Nephrolithotomy, each playing a crucial role in managing kidney stones effectively. Medications are essential for pain relief and preventing stone formation, catering to a large patient population who prefer non-invasive approaches. Extracorporeal Shock Wave Lithotripsy stands out as a popular non-invasive option that utilizes shock waves to fragment stones, thus minimizing recovery time and hospital stays, reflecting the increasing preference for outpatient therapies. Ureteroscopy offers direct access to stones within the urinary tract and is particularly beneficial for larger stones, allowing for immediate removal which is vital in urgent cases. Lastly, Percutaneous Nephrolithotomy is often reserved for complex or large stone cases, and it signifies a critical intervention in advanced scenarios. As kidney stone prevalence rises in South Korea owing to lifestyle changes, each of these treatment methods showcases unique advantages, driving growth within the South Korea Kidney Stones Market and enhancing patient outcomes in a region increasingly focused on effective renal healthcare solutions. ### Kidney Stones Market Diagnosis Insights The Diagnosis segment of the South Korea Kidney Stones Market demonstrates significant growth potential, largely driven by the rising prevalence of kidney stones among the population. With advanced healthcare infrastructure and increasing awareness among patients, diagnostic methods such as Ultrasound and CT scans have gained notable adoption in clinical settings. Ultrasound is particularly valued for its non-invasive nature and lack of radiation exposure, making it a preferred choice for initial assessments. Meanwhile, Intravenous Pyelography offers detailed imaging, which enhances the accuracy of diagnoses, thereby boosting the overall efficacy of treatment strategies. CT scans are regarded as particularly important for their ability to provide high-resolution images that assist in identifying stone composition and location. X-Ray remains a basic yet essential tool in diagnosis for some cases, showcasing its integral role in the diagnostic process. The growing focus on early diagnosis and timely treatment interventions in South Korea further elevates the importance of these diagnostic methods, suggesting a robust future for the segment. Moreover, the strong support from government health initiatives aimed at reducing kidney stone incidences reinforces the evolution of the South Korea Kidney Stones Market, creating opportunities for technological advancements in diagnostic tools. Overall, this segment exhibits a promising landscape characterized by innovation and increased healthcare expenditure, positioning it as a critical component of kidney stone management in South Korea. ## South Korea Kidney Stones Market Key Players and Competitive Insights The South Korea Kidney Stones Market is a dynamic arena characterized by heightened competition among various entities focused on the prevention, identification, and treatment of kidney-related ailments. The rise in lifestyle diseases, coupled with unhealthy dietary habits, has led to an increasing prevalence of kidney stones in the region, creating a robust demand for innovative solutions and therapies. Companies are actively engaged in research and development efforts to enhance treatment options, which include medical management, surgical interventions, and minimally invasive procedures. As healthcare systems evolve, the interplay between healthcare providers, pharmaceutical companies, and medical device manufacturers plays a crucial role in shaping market strategies and operational effectiveness, thereby influencing patient outcomes and market dynamics. Gachon University holds a significant position in the South Korea Kidney Stones Market, primarily recognized for its advanced medical research and educational contributions. As an educational institution, Gachon University emphasizes a multidisciplinary approach to healthcare, fostering a collaborative environment for researchers and healthcare practitioners to develop novel treatment methodologies. Its strengths lie in specializing in urology and nephrology, where faculty members are engaged in cutting-edge research related to kidney stones. Furthermore, Gachon University has established partnerships with various healthcare organizations, which enhances its clinical exposure and improves patient care dynamics in the realm of kidney stone management, thereby further solidifying its reputation and impact within the South Korean healthcare landscape. Hanmi Pharmaceutical is well-positioned within the South Korea Kidney Stones Market, known for its dedication to pharmaceutical innovations aimed at urological conditions. The company offers a range of products that facilitate the treatment and prevention of kidney stones, demonstrating a commitment to improving patient quality of life. With a strong market presence in South Korea, Hanmi Pharmaceutical's strengths lie in its extensive research and development capabilities, which are evident in its pipeline of proprietary medications designed specifically for kidney stone management. The company has pursued strategic mergers and acquisitions to bolster its operational efficiencies and expand its portfolio, allowing for enhanced service offerings in urology-focused therapies. These initiatives reflect Hanmi Pharmaceutical’s proactive approach to maintain its competitive edge and cater to the evolving needs of healthcare professionals and patients dealing with kidney stone issues. ### Key Companies in the South Korea Kidney Stones Market Include - Gachon University - Hanmi Pharmaceutical - Severance Hospital - Sungkyunkwan University - Busan National University - [**Samsung Medison**](https://usa.samsunghealthcare.com/https/app.hubspot.com/content/384045/edit/14114769878/content-0-0-1-1-0-0-0-0) - DongA ST - Korea Institute of Radiological & Medical Sciences - NMC Healthcare - Kyungpook National University - Korea University Anam Hospital - LG Chem - Daewoong Pharmaceutical - Asan Medical Center - Chungbuk National University - Korea University Anam Hospital ## South Korea Kidney Stones Market Industry Developments Recent developments in the South Korea Kidney Stones Market have seen significant advancements, particularly in the integration of innovative health technologies and research initiatives. For instance, Gachon University and Korea University Anam Hospital have been collaborating on cutting-edge research focused on enhancing diagnostic methodologies for kidney stones. Additionally, Hanmi Pharmaceutical is actively engaging in the development of medications aimed at reducing the recurrence of kidney stones. Severance Hospital and Samsung Medison are also investing in advanced imaging techniques to diagnose and treat kidney stones more effectively. Regarding mergers and acquisitions, notable activities included a partnership between Asan Medical Center and DongA ST in July 2023 to enhance their urology treatment capabilities through combined research efforts. Over the past two to three years, the market has experienced substantial growth, with LG Chem and Daewoong Pharmaceutical both reporting expansion in their product lines related to kidney health, illustrating a broader trend towards preventative healthcare solutions. The Korean government has emphasized the importance of addressing kidney stone prevalence with new health policies aimed at improving diagnostic and treatment facilities nationwide. ## South Korea Kidney Stones Market Segmentation Insights ### Kidney Stones Market Type Outlook - Calcium Oxalate Stones - Uric Acid - Struvite Kidney Stones - Cystine Stones - Calcium Phosphate Stones ### Kidney Stones Market Treatment Type Outlook - Medications - Extracorporeal Shock Wave Lithotripsy - Ureteroscopy - Percutaneous Nephrolithotomy ### Kidney Stones Market Diagnosis Outlook - Ultrasound - Intravenous Pyelography - CT scan - X-Ray - Others ## Market Drivers ### Rising Geriatric Population The aging population in South Korea is a significant driver of the kidney stones market. As individuals age, the risk of developing kidney stones increases due to various physiological changes and comorbidities. Current demographic data indicates that approximately 15% of the South Korean population is aged 65 and older, a figure that is projected to rise in the coming years. This demographic shift suggests a growing need for healthcare services tailored to older adults, including those suffering from kidney stones. Consequently, healthcare providers may need to adapt their strategies to cater to this demographic, potentially leading to an increase in the availability of specialized treatments and preventive measures. The implications of an aging population on the kidney stones market are profound, as it may drive innovation and investment in age-specific healthcare solutions. ### Increasing Prevalence of Risk Factors The kidney stones market in South Korea is experiencing growth due to the increasing prevalence of risk factors associated with kidney stones. Factors such as obesity, diabetes, and dietary habits contribute significantly to the incidence of kidney stones. Recent studies indicate that approximately 30% of the South Korean population is classified as overweight, which correlates with a higher likelihood of developing kidney stones. Additionally, the consumption of high-sodium and high-oxalate foods has been on the rise, further exacerbating the situation. This trend suggests that as more individuals adopt unhealthy lifestyles, the demand for kidney stones market solutions, including preventive measures and treatment options, is likely to increase. Consequently, healthcare providers and pharmaceutical companies may focus on developing targeted therapies and educational programs to address these risk factors effectively. ### Technological Innovations in Treatment Technological advancements in the treatment of kidney stones are significantly influencing the kidney stones market in South Korea. Innovations such as minimally invasive surgical techniques, laser lithotripsy, and advanced imaging technologies have improved patient outcomes and reduced recovery times. For instance, the introduction of flexible ureteroscopy has allowed for more effective removal of stones with fewer complications. The market for these advanced treatment options is projected to grow, with estimates suggesting a compound annual growth rate (CAGR) of around 8% over the next five years. As healthcare facilities adopt these technologies, patient satisfaction is likely to increase, driving further demand in the kidney stones market. This trend indicates a shift towards more efficient and patient-friendly treatment modalities, which could reshape the competitive landscape of the industry. ### Increased Focus on Preventive Healthcare There is a notable shift towards preventive healthcare in South Korea, which is influencing the kidney stones market. As awareness of the importance of lifestyle choices in preventing kidney stones grows, more individuals are seeking preventive measures. This trend is reflected in the rising demand for dietary supplements, hydration products, and educational resources aimed at reducing the risk of kidney stones. Market data suggests that the preventive segment of the kidney stones market could account for approximately 25% of total market revenue by 2026. Healthcare providers are increasingly emphasizing the role of prevention, leading to the development of programs that educate the public on risk factors and healthy lifestyle choices. This proactive approach may not only reduce the incidence of kidney stones but also reshape consumer behavior and market dynamics in the kidney stones market. ### Government Initiatives and Healthcare Policies Government initiatives aimed at improving healthcare access and quality are playing a crucial role in shaping the kidney stones market in South Korea. Policies that promote preventive healthcare and early diagnosis are likely to enhance awareness and treatment of kidney stones. For example, the South Korean government has implemented programs to subsidize medical costs for kidney stone treatments, making them more accessible to the population. This has resulted in an increase in the number of patients seeking treatment, thereby expanding the kidney stones market. Furthermore, public health campaigns focusing on hydration and dietary modifications are expected to contribute to a decrease in the incidence of kidney stones, which may also influence market dynamics. The interplay between government support and market growth appears to be a pivotal factor in the ongoing evolution of the kidney stones market. ## Future Outlook The [Kidney Stones Market](https://www.marketresearchfuture.com/reports/kidney-stones-market-1745) is projected to grow at a 5.23% CAGR from 2025 to 2035, driven by increasing prevalence, advancements in treatment technologies, and rising healthcare expenditure. **New opportunities:** - Development of minimally invasive surgical techniques for kidney stone removal. - Expansion of telehealth services for remote patient monitoring and consultations. - Investment in AI-driven diagnostic tools for early detection of kidney stones. By 2035, the kidney stones market is expected to achieve substantial growth, reflecting evolving healthcare dynamics. ## Segment Insights ### By Type: Calcium Oxalate Stones (Largest) vs. Uric Acid (Fastest-Growing) In the South Korea kidney stones market, Calcium Oxalate Stones dominate the segment, capturing a significant market share due to their prevalence among patients. Following this, Uric Acid stones are emerging rapidly, accounting for an increasing portion of the market as awareness and diagnosis improve. Struvite, Cystine, and Calcium Phosphate Stones have comparatively smaller shares but are notable within specific patient populations. Growth trends indicate a rising incidence of kidney stones, driven by dietary factors, increased obesity rates, and rising healthcare expenditure. The continued advancements in diagnostic technologies also play a crucial role, as they facilitate better detection and management of various types of stones. Uric Acid stones, in particular, show promise for future growth owing to lifestyle changes among the population, leading to higher rates of uric acid crystallization. Calcium Oxalate Stones (Dominant) vs. Uric Acid (Emerging) Calcium Oxalate Stones represent the dominant type in the market, primarily attributed to dietary influences and genetic predispositions among the population. These stones are often formed from calcium and oxalate, making them common due to the frequent intake of oxalate-rich foods such as spinach and nuts. In contrast, Uric Acid stones are emerging as a significant segment, linked to dietary habits and metabolic disorders. They result from high levels of uric acid in the urine, which can be exacerbated by diets low in fluid intake and high in purine-rich foods. Both segments necessitate tailored treatment and dietary management strategies to effectively address patient needs in the South Korea kidney stones market. ### By Treatment Type: Extracorporeal Shock Wave Lithotripsy (Largest) vs. Ureteroscopy (Fastest-Growing) The South Korea kidney stones market exhibits a diverse treatment landscape, with Extracorporeal Shock Wave Lithotripsy (ESWL) holding the largest market share. ESWL is preferred due to its non-invasive nature and effective stone fragmentation capabilities. In contrast, Ureteroscopy is witnessing significant growth thanks to advancements in technology and increased patient awareness. This treatment option is gaining traction in cases where ESWL is not effective, allowing it to capture an expanding share of the market. Growth trends indicate a shift towards minimally invasive procedures, driven by advancements in medical technologies and techniques. The rising prevalence of kidney stones in the population fuels demand for effective treatment options. Furthermore, increased healthcare spending and patient preference for outpatient procedures contribute to the upward trajectory of the Ureteroscopy treatment segment, establishing it as an emergent force in the market. Extracorporeal Shock Wave Lithotripsy (Dominant) vs. Ureteroscopy (Emerging) Extracorporeal Shock Wave Lithotripsy (ESWL) remains the dominant treatment modality in the South Korea kidney stones market, attributed to its non-invasive approach and successful outcomes. Patients favor ESWL for its ability to effectively treat a variety of stone sizes without significant recovery time. Ureteroscopy, on the other hand, is becoming increasingly recognized as an emerging option, particularly for stones that are difficult to reach or not amenable to ESWL. The advances in ureteroscopy technology have made it a more viable choice for urologists, leading to improved efficacy and patient satisfaction rates, and its growth is reflective of shifting patient preferences and clinical practices. ### By Diagnosis: CT Scan (Largest) vs. Ultrasound (Fastest-Growing) In the South Korea kidney stones market, the diagnosis segment is predominantly led by CT Scans, which hold the largest market share. With high accuracy and speed, CT Scans have become the preferred choice among healthcare providers, ensuring efficient patient management. On the other hand, Ultrasound is witnessing a notable surge in adoption due to its non-invasive nature and immediate results, making it a favored option in outpatient settings. As healthcare moves towards more patient-centric approaches, the growth of the ultrasound segment can be attributed to technological advancements and increased awareness about kidney stone diseases. Furthermore, the emphasis on cost-effective and radiation-free diagnostics is likely to bolster the use of ultrasound. Conversely, CT Scans, despite being established, face competition from emerging modalities that focus on reducing radiation exposure and enhancing patient comfort. CT Scan (Dominant) vs. Ultrasound (Emerging) CT Scans are recognized as the dominant method for diagnosing kidney stones due to their unparalleled precision and ability to provide detailed images. They facilitate accurate diagnosis and guide treatment decisions, making them a critical component in the management of kidney stones. Meanwhile, Ultrasound is emerging as a compelling alternative, particularly in pediatrics and for pregnant patients, where radiation exposure is a concern. The increasing preference for non-invasive techniques among both patients and physicians enhances Ultrasound's market position. As the healthcare landscape shifts towards safer diagnostic tools, both CT Scans and Ultrasound will continue to evolve, responding to the demands for efficiency and patient safety. ## Competitive Benchmarking The kidney stones market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Boston Scientific (US), Medtronic (US), and Olympus Corporation (JP) are actively pursuing growth through technological advancements and regional expansions. Boston Scientific (US) focuses on developing minimally invasive solutions, which aligns with the growing demand for less invasive treatment options. Medtronic (US) emphasizes digital health integration, enhancing patient outcomes through connected devices. Meanwhile, Olympus Corporation (JP) leverages its expertise in endoscopic technologies to maintain a competitive edge, indicating a trend towards specialized, high-tech solutions in the market.The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing. The market structure appears moderately fragmented, with several players vying for market share while also collaborating on various fronts. This collective influence of key players fosters a dynamic environment where innovation and operational efficiency are paramount, allowing companies to respond swiftly to market demands and regulatory changes. In October Medtronic (US) announced a strategic partnership with a leading South Korean healthcare provider to enhance the distribution of its advanced kidney stone management technologies. This collaboration is expected to streamline access to innovative treatment options, thereby improving patient care and expanding Medtronic's footprint in the region. Such partnerships are indicative of a broader trend where companies seek to leverage local expertise to navigate regulatory landscapes and enhance market penetration. In September Boston Scientific (US) launched a new line of ureteral stents designed specifically for the Asian market, which includes South Korea. This product launch not only demonstrates Boston Scientific's commitment to addressing regional needs but also highlights the importance of tailored solutions in gaining competitive advantage. The introduction of these stents is likely to enhance patient comfort and treatment efficacy, further solidifying the company's position in the market. In August Olympus Corporation (JP) unveiled a cutting-edge endoscopic system aimed at improving the detection and treatment of kidney stones. This technological advancement underscores Olympus's focus on innovation and its strategic intent to lead in minimally invasive procedures. By enhancing the capabilities of its endoscopic systems, Olympus is poised to capture a larger share of the market, particularly among healthcare providers seeking advanced solutions. As of November the competitive trends in the kidney stones market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Companies are forming strategic alliances to enhance their technological capabilities and improve patient outcomes. The shift from price-based competition to a focus on innovation and supply chain reliability is evident, suggesting that future competitive differentiation will hinge on the ability to deliver advanced, patient-centric solutions that leverage technology effectively. ## Recent News & Developments Recent developments in the South Korea Kidney Stones Market have seen significant advancements, particularly in the integration of innovative health technologies and research initiatives. For instance, Gachon University and Korea University Anam Hospital have been collaborating on cutting-edge research focused on enhancing diagnostic methodologies for kidney stones. Additionally, Hanmi Pharmaceutical is actively engaging in the development of medications aimed at reducing the recurrence of kidney stones. Severance Hospital and Samsung Medison are also investing in advanced imaging techniques to diagnose and treat kidney stones more effectively. Regarding mergers and acquisitions, notable activities included a partnership between Asan Medical Center and DongA ST in July 2023 to enhance their urology treatment capabilities through combined research efforts. Over the past two to three years, the market has experienced substantial growth, with LG Chem and Daewoong Pharmaceutical both reporting expansion in their product lines related to kidney health, illustrating a broader trend towards preventative healthcare solutions. The Korean government has emphasized the importance of addressing kidney stone prevalence with new health policies aimed at improving diagnostic and treatment facilities nationwide. ## South Korea Kidney Stones Market Segmentation Insights ### Kidney Stones Market Type Outlook - Calcium Oxalate Stones - Uric Acid - Struvite Kidney Stones - Cystine Stones - Calcium Phosphate Stones ### Kidney Stones Market Treatment Type Outlook - Medications - Extracorporeal Shock Wave Lithotripsy - Ureteroscopy - Percutaneous Nephrolithotomy ### Kidney Stones Market Diagnosis Outlook - Ultrasound - Intravenous Pyelography - CT scan - X-Ray - Others ## Report Scope | MARKET SIZE 2024 | 54.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 56.82(USD Million) | | MARKET SIZE 2035 | 94.6(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.23% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), C.R. Bard (US), Cook Medical (US), Olympus Corporation (JP), Stryker Corporation (US), Terumo Corporation (JP), Karl Storz (DE) | | Segments Covered | Type, Treatment Type, Diagnosis | | Key Market Opportunities | Advancements in minimally invasive treatment technologies enhance patient outcomes in the kidney stones market. | | Key Market Dynamics | Rising prevalence of kidney stones drives demand for advanced treatment options and innovative technologies in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What is the current valuation of the kidney stones market in South Korea?** A: The market valuation was $54.0 Million in 2024. **Q: What is the projected market size for kidney stones in South Korea by 2035?** A: The projected valuation for 2035 is $94.6 Million. **Q: What is the expected CAGR for the South Korea kidney stones market from 2025 to 2035?** A: The expected CAGR during this period is 5.23%. **Q: Which companies are the key players in the South Korea kidney stones market?** A: Key players include Boston Scientific, Medtronic, Johnson & Johnson, and C.R. Bard. **Q: What are the main types of kidney stones and their market values?** A: Calcium Oxalate Stones were valued at $20.0 Million, while Uric Acid stones reached $10.0 Million in 2024. **Q: How does the treatment type segment perform in the South Korea kidney stones market?** A: Ureteroscopy had a market value of $20.0 Million in 2024, indicating strong demand. **Q: What diagnostic methods are used in the kidney stones market, and what are their valuations?** A: CT Scans were valued at $20.0 Million, highlighting their importance in diagnosis. **Q: What is the market value of medications used for kidney stones in South Korea?** A: Medications had a market value of $10.0 Million in 2024. **Q: How do the valuations of struvite kidney stones compare to cystine stones?** A: Struvite Kidney Stones were valued at $8.0 Million, whereas Cystine Stones reached $5.0 Million. **Q: What is the growth outlook for the kidney stones market in South Korea?** A: The market is expected to grow significantly, reaching $94.6 Million by 2035. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-kidney-stones-market-52860*